Skip to content

Collection of prospective 2-year data from the first 10 patients after Ankle Spacer implantation

Collection of prospective 2-year data from the first 10 patients after Ankle Spacer implantation

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00023635
Enrollment
10
Registered
2021-02-08
Start date
2019-01-18
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Osteochondrosis dissecans : ankle and foot [tarsal, metatarsal, toes, ankle, other joints of the foot].

Interventions

Group 1: Patients will be surgically fitted with an ankle spacer. At follow-up (3 months, 6 months, 12 months, and 24 months), the clinical performance of the implant will be measured using clinical s

Sponsors

Orthopädische Klinik der Medizinischen Hochschule im Diakovere Annastift
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Age 18 - 80 years - Indication for implantation of the Ankle Spacer

Exclusion criteria

Exclusion criteria: - Florid infection - Relevant circulatory disorders of the affected leg - Malposition of the OSG > 5° varus or valgus - Fractures of the OSG or ankle joint that occurred less than 6 months ago - Obesity with a BMI > 30 kg/m2 - Known insulin-dependent diabetes mellitus - Known rheumatoid arthritis - Osteoarthritis of the OSG II° or higher according to Kellgren/Lawrence - Deformation of the OSG that does not allow implantation of the Ankle Spacer

Design outcomes

Primary

MeasureTime frame
The aim is to collect descriptive data on 10 patients for the following parameters: - Visual Analog Scale (VAS) for pain (1-10) at rest and during exertion/walking. - Ankle-Foot Scale (AOFAS) [18]. - Foot and Ankle Outcome Score (FAOS) [19] - Short-Form-36 Health Survey (SF-36) [20] - Range of motion (measured by goniometer). - Revision rate and implant survival time - Adverse event - Operation time - Length of hospital stay

Secondary

MeasureTime frame
First data collection and descriptive evaluation for a new medical device

Countries

Germany

Contacts

Public ContactYvonne Noll

Orthopädische Klinik der Medizinischen Hochschule Hannover im Diakovere Annastift, Leitung Klinisches Studienmanagement

yvonne.noll@diakovere.de0511-5354-649

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026